
ORXOF
Healthcare · Drug Manufacturers - Specialty & Generic · $4.9M market cap
$0.08810.00 (0.0%)Nov 13, 9:30 AM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Sep 30, 2026
EPS trend, 90 days to now
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Oct 22, 2026 | After the close | -2.10 | — | — |
| Jan 25, 2023 | After the close | -1.80 | -2.67 | -48.3% |
| Nov 2, 2022 | After the close | -1.68 | -0.77 | +54.2% |
| Jul 13, 2022 | After the close | -1.20 | -1.04 | +13.3% |
| Apr 27, 2022 | After the close | -0.20 | -0.69 | -245.0% |
| Jan 26, 2022 | After the close | -1.70 | -1.92 | -12.9% |
| Nov 2, 2021 | After the close | -1.69 | -1.51 | +10.7% |
| Jul 14, 2021 | After the close | -1.55 | -2.15 | -38.7% |
| Apr 28, 2021 | After the close | -1.16 | -0.92 | +20.7% |
| Jan 27, 2021 | After the close | -3.49 | -1.45 | +58.5% |
| Nov 3, 2020 | After the close | -0.76 | -2.45 | -222.4% |
| Jul 15, 2020 | After the close | 0.47 | -0.94 | -300.0% |
| Apr 27, 2020 | After the close | 0.71 | 2.34 |
Orexo AB (publ), a pharmaceutical company, provides advance treatments for severe diseases and life-saving rescue medications in the United States, European Union, the United Kingdom, and internationally. Its products include Zubsolv tablets for the treatment of opioid use disorder; Abstral for the treatment of breakthrough pain in cancer patients; Edluar for the treatment of insomnia; and Diabact UBT for the…
| +229.6% |
| Jan 29, 2020 | After the close | 2.20 | 1.10 | -50.0% |
| Oct 23, 2019 | After the close | 2.22 | 3.16 | +42.3% |
| Jul 10, 2019 | After the close | 0.88 | 1.51 | +71.6% |
| May 1, 2019 | After the close | -0.23 | 0.40 | +273.9% |
| Jan 29, 2019 | After the close | 1.85 | 1.47 | -20.5% |
| Oct 24, 2018 | After the close | 1.36 | 1.77 | +30.1% |
| Jul 10, 2018 | After the close | 0.34 | 1.45 | +326.5% |
| Apr 25, 2018 | After the close | -0.70 | -0.75 | -7.1% |
| Jan 24, 2018 | After the close | — | -0.09 | — |